Strong trader consensus at 93.5% against a new pandemic in 2026 stems from ongoing global surveillance by the WHO and CDC showing no novel pathogen meeting pandemic criteria through early August. Known respiratory viruses like SARS-CoV-2 continue circulating at low to moderate levels with seasonal patterns, while localized outbreaks such as Bundibugyo virus in the DRC remain geographically contained without sustained human-to-human transmission chains. Historical precedent indicates pandemics typically require efficient airborne spread from immunologically naive populations, a threshold not crossed by current zoonotic or variant activity. Market-implied odds could shift with rapid emergence of a high-transmissibility strain or undetected spillover before year-end surveillance updates.